Thus, combination alloferon/zanamivir might also be an effective treatment for inflammatory responses caused by infection with respiratory viruses, as well as for regulation of inflammatory responses in the lung mediated by IL-6 and MIP-1a. This evidence concerns the gene CCL3 and infection.